AstraZeneca gives Goldstein leading role in push to sequence 2M genomes

AstraZeneca gives Goldstein leading role in push to sequence 2M genomes

AstraZeneca ($AZN) has named David Goldstein as chief adviser to its new genome sequencing drive. The appointment gives a professor known for his work on genetic drivers of responses to hepatitis C drugs and inherited disorders influence over the direction of AstraZeneca’s move to build and make use of a database of 2 million whole genomes.

Read more here.


Leave a Reply

Your email address will not be published. Required fields are marked *


Home / Featured (sidebar) / AstraZeneca gives Goldstein leading role in push to sequence 2M genomes